Division of Pulmonary, Critical Care, and Sleep Medicine (C.E.B., J.M.S., P.J.L., J.R.C., R.A.E.), University of Washington Seattle, WA, USA; Cambia Palliative Care Center of Excellence at UW Medicine (C.E.B., J.M.S., J.R.C., R.A.E.), Seattle, WA, USA; Department of Bioethics and Humanities (C.E.B.), University of Washington, Seattle, WA, USA.
Cambia Palliative Care Center of Excellence at UW Medicine (C.E.B., J.M.S., J.R.C., R.A.E.), Seattle, WA, USA; Division of Cardiology (C.E.B., J.M.S., P.J.L., J.R.C., R.A.E.), University of Washington, Seattle, WA, USA.
J Pain Symptom Manage. 2023 Apr;65(4):e329-e335. doi: 10.1016/j.jpainsymman.2022.11.027. Epub 2022 Dec 13.
Physicians who specialize in pulmonary arterial hypertension (PAH) care for patients facing a serious, life-limiting illness. Palliative care is underutilized in patients with PAH, and little is known about how best to provide palliative care to this patient population.
Using a qualitative approach, assess physicians' perspectives on barriers and facilitators to the use of palliative care in PAH.
Participants were board-certified pulmonologists and cardiologists recruited from the Pulmonary Hypertension Association's list of physician specialists and academic center websites. We performed one-on-one semi-structured interviews that were recorded, transcribed, and analyzed using thematic analysis.
Twelve physicians participated in the study, with a median age of 48.5 years and 20.5 years of clinical experience caring for patients with PAH. We identified the following themes and associated barriers and facilitators to effective implementation of palliative care for patients with PAH: a tailored approach to the individual patient; a PAH-specialist-led culture of care; effective collaboration with palliative care clinicians; and limitations imposed by health systems.
PAH physicians are open to palliative care for their patients and are willing to partner with palliative care clinicians to implement this effectively and in the right setting. Areas for targeted improvement in enhancing palliative care for patients with PAH exist, especially enhancing collaboration between PAH physicians and palliative care specialists and navigating barriers in health systems.
专门治疗肺动脉高压 (PAH) 的医生负责照顾面临严重、危及生命的疾病的患者。姑息治疗在 PAH 患者中未得到充分利用,对于如何为这一患者群体提供最佳姑息治疗知之甚少。
采用定性方法,评估医生对在 PAH 中使用姑息治疗的障碍和促进因素的看法。
参与者是从肺动脉高压协会的医生专家名单和学术中心网站招募的经过董事会认证的肺科医生和心脏病专家。我们进行了一对一的半结构化访谈,使用主题分析对访谈进行记录、转录和分析。
12 名医生参与了这项研究,他们的中位年龄为 48.5 岁,有 20.5 年的 PAH 患者护理临床经验。我们确定了以下主题以及与为 PAH 患者有效实施姑息治疗相关的障碍和促进因素:针对个体患者的量身定制方法;以 PAH 专家为主导的护理文化;与姑息治疗临床医生的有效合作;以及健康系统施加的限制。
PAH 医生对他们的患者接受姑息治疗持开放态度,并愿意与姑息治疗临床医生合作,以在适当的环境中有效实施姑息治疗。在增强 PAH 患者姑息治疗方面存在有针对性的改进领域,特别是加强 PAH 医生和姑息治疗专家之间的合作以及克服健康系统中的障碍。